universal influenza vaccine (M2 protein)

The universal influenza vaccine (M2 protein) is a recombinant protein vaccine candidate developed by Vaxine, currently in preclinical stages. It targets the M2 ion channel protein, which is highly conserved across various influenza A virus strains. Unlike traditional vaccines that focus on the highly mutable hemagglutinin protein, this approach aims to induce broad-spectrum immunity that could protect against multiple seasonal and potentially pandemic influenza strains. The vaccine is designed to provide a more durable and cross-reactive immune response, potentially reducing the need for frequent vaccine updates.

Other names

M2 protein influenza vaccineM-2 protein influenza vaccineM 2 protein influenza vaccine